REGENERON PHARMACEUTICALS, INC. Restricted Cash, Noncurrent
REGENERON PHARMACEUTICALS, INC. (REGN) had Restricted Cash, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2026-02-04
- 2025-12-31: Restricted Cash, Noncurrent $0.00.
- 2025-03-31: Restricted Cash, Noncurrent $0.00.
- 2024-12-31: Restricted Cash, Noncurrent $0.00.
- 2024-09-30: Restricted Cash, Noncurrent $0.00.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-04 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-29 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-04 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $7.80M 10-Q · filed 2025-04-29 |
| 2023-12-31 | $7.80M 10-K · filed 2026-02-04 |
| 2023-09-30 | $7.90M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $7.00M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $12.50M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $13.50M 10-K · filed 2025-02-05 |
| 2022-09-30 | $13.50M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $13.50M 10-Q · filed 2023-08-03 |
| 2021-12-31 | $12.50M 10-K · filed 2024-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |